MAPT and Alzheimer disease: Considering the changes of AHNP neurons in MCI donors and the alterations in expression of ADNPs within cognitive regions during aging, an alternative to our hypothesis could be that these neurons increase the risk of cognitive decline and tau-related neurodegenerative diseases, rather than being AD-specific.